Hologic (HOLX) Issues Strong Prelim. Q4 Revenue Update

Hologic (Nasdaq: HOLX) announced preliminary revenue results for its first fiscal quarter ended December 27, 2014.

The Company expects to report total revenues of approximately $653 million, a 7% increase compared to the prior year period and an 8% increase on a constant currency basis. (The Street sees Q4 revs of $630.8 million.) This exceeds the Company's previous quarterly revenue guidance of $625-$635 million. Preliminary revenues by business segment are:

In addition, the Company announced that it voluntarily prepaid $300 million of principal on its Term Loan B facility in December 2014.

"Hologic posted strong organic revenue growth across the board in the first quarter," said Steve MacMillan, the Company's president and chief executive officer. "This better-than-expected performance, combined with the voluntary prepayment of debt, provide further evidence of a turnaround that continues to build momentum. While we're pleased with our results thus far, we're also mindful that there's still much to do."

Hologic is providing these business updates in advance of the Company's participation in the 33rd Annual J.P. Morgan Healthcare Conference, which begins today. The Company has posted its new conference presentation to the investor relations section of its website at http://investors.hologic.com/.

The preliminary revenue results described in this press release are estimates only and are subject to revision until the Company reports its full financial results for the first quarter of fiscal 2015 on January 28, 2015.

You May Also Be Interested In

• Morgan Stanley CEO: investment banking momentum is building - Conference Call
• Main Street Capital (MAIN) Reports Prelim Q1 Results
• CBOE Holdings (CBOE) PT Lowered to $163 at JPMorgan